Macro Group Pharmaceuticals (Macro Capital) S.A.E Share Price
Stocks
MCRO
EGS7D971C011
Pharmaceuticals
|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.590 EGP | +6.00% |
|
+6.71% | +39.47% |
| 17/05 | Macro Group Pharmaceutical Q1 consol profit egp 33.3 million | RE |
| 20/02 | Macro Group Pharmaceuticals (Macro Capital) S.A.E Reports Earnings Results for the Full Year Ended December 31, 2025 | CI |
| Market Cap | 91Cr 1.81Cr 1.57Cr 1.47Cr 1.35Cr 2.54Cr 172.41Cr 2.58Cr 17Cr 6.78Cr 86Cr 6.79Cr 6.64Cr 283.59Cr | P/E 2026 * |
26.5x | P/E 2027 * | 17.7x |
|---|---|---|---|---|---|
| Enterprise Value | 83Cr 1.65Cr 1.43Cr 1.34Cr 1.23Cr 2.32Cr 157.26Cr 2.36Cr 16Cr 6.18Cr 78Cr 6.2Cr 6.06Cr 258.66Cr | EV / Sales 2026 * |
0.69x | EV / Sales 2027 * | 0.51x |
| Free-Float |
42% | Yield 2026 * |
1.89% | Yield 2027 * | 2.52% |
| 1 day | +6.00% | ||
| 1 week | +6.71% | ||
| Current month | +6.71% | ||
| 1 month | +31.40% | ||
| 3 months | +26.19% | ||
| 6 months | +12.77% | ||
| Current year | +39.47% |
| 1 week | 1.45 |  | 1.6 |
| 1 month | 1.21 | | 1.6 |
| Current year | 1.02 | | 1.68 |
| 1 year | 0.81 | | 4.11 |
| 3 years | 0.81 | | 4.11 |
| 5 years | 0.81 | | 5.28 |
| 10 years | 0.81 | | 5.28 |
| Manager | Title | Age | Since |
|---|---|---|---|
Khaled Kamel
CEO | Chief Executive Officer | - | - |
Zeina Shahin
IRC | Investor Relations Contact | - | - |
Tamer Raouf
SAM | Sales & Marketing | - | 01/01/2022 |
| Director | Title | Age | Since |
|---|---|---|---|
Ahmed El-Nayeb
CHM | Chairman | - | 01/01/2002 |
Tamir Saeed
BRD | Director/Board Member | - | 01/01/2021 |
Norbert Lurz
BRD | Director/Board Member | - | 01/01/2021 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +6.00% | +6.71% | -23.92% | -40.00% | 1.67Cr | |
| -2.39% | -6.36% | +47.10% | +149.66% | 1,02400Cr | |
| -0.76% | -4.34% | +52.04% | +49.09% | 62TCr | |
| -2.33% | -4.60% | +25.55% | +64.44% | 44TCr | |
| +0.68% | -1.14% | +38.47% | +33.36% | 35TCr | |
| -1.66% | -3.13% | +32.18% | +39.79% | 30TCr | |
| -8.96% | -10.77% | +3.57% | +5.50% | 26TCr | |
| -1.37% | -7.41% | -2.10% | -43.67% | 21TCr | |
| -1.63% | +0.69% | +27.62% | +64.23% | 21TCr | |
| +0.72% | +0.48% | +15.88% | +73.64% | 16TCr | |
| Average | -0.78% | -2.44% | +21.64% | +39.60% | 35.74TCr | |
| Weighted average by Cap. | -0.98% | -3.91% | +34.56% | +70.87% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 119Cr 2.37Cr 2.06Cr 1.93Cr 1.77Cr 3.33Cr 226.3Cr 3.39Cr 23Cr 8.9Cr 112.85Cr 8.92Cr 8.72Cr 372.23Cr | 155.2Cr 3.1Cr 2.69Cr 2.51Cr 2.31Cr 4.35Cr 295.14Cr 4.42Cr 30Cr 12Cr 147.18Cr 12Cr 11Cr 485.46Cr |
| Net income | 21Cr 41.1L 35.72L 33.35L 30.61L 57.73L 39Cr 58.73L 3.93Cr 1.54Cr 20Cr 1.54Cr 1.51Cr 64Cr | 28Cr 56.46L 49.07L 45.81L 42.06L 79.3L 54Cr 80.69L 5.4Cr 2.12Cr 27Cr 2.12Cr 2.07Cr 89Cr |
| Net Debt | -7.97Cr -15.9L -13.82L -12.9L -11.84L -22.33L -15Cr -22.72L -1.52Cr -59.58L -7.56Cr -59.73L -58.41L -25Cr | -11Cr -21.95L -19.07L -17.81L -16.35L -30.82L -21Cr -31.36L -2.1Cr -82.24L -10Cr -82.44L -80.61L -34Cr |
Employees
-
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 03/26/03 | EGP 1.590 | +6.00% | 17,19,02,548 |
| 02/26/02 | EGP 1.500 | +0.67% | 10,55,58,462 |
| 30/26/30 | EGP 1.490 | -2.61% | 7,44,98,234 |
| 29/26/29 | EGP 1.530 | 0.00% | 18,97,15,387 |
| 28/26/28 | EGP 1.530 | +2.68% | 9,51,86,580 |
Sell
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
1.590EGP
Average target price
1.570EGP
Spread / Average Target
-1.26%
Annual profits - Rate of surprise
- Stock Market
- Stocks
- MCRO Stock
Select your edition
All financial news and data tailored to specific country editions
